Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis

Author： Mesgarpour Bita   Heidinger Benedikt   Schwameis Michael   Kienbacher Calvin   Walsh Cathal   Schmitz Susanne   Herkner Harald  

Publisher： Springer Publishing Company

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.39, Iss.11, 2013-11, pp. : 1896-1908

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of Anaemia with Erythropoiesis-Stimulating Agents in Patients with Chronic Kidney Disease Does Not Lower Mortality and May Increase Cardiovascular Risk: A Meta-Analysis

By  

Nephron Clin Pract, Vol. 121, Iss. 3-4, 2012-11 ,pp. : c95-c101

Karger

Access to resources Recommend Favorite

Twist and Shout: One Decade of Meta-Analyses of Erythropoiesis-Stimulating Agents in Cancer Patients

By  

Acta Haematologica, Vol. 125, Iss. 1-2, 2010-12 ,pp. : 55-67

Karger

Access to resources Recommend Favorite

Use and cost of erythropoiesis-stimulating agents in patients with cancer

By Daniel Gregory   Hurley Dana   Whyte Joanna L.   Willey Vincent   Wilson Marcus   Kallich Joel  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1775-1784

Informa Healthcare

Access to resources Recommend Favorite

Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients: A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

By Krag Mette   Perner Anders   Wetterslev Jørn   Wise Matt   Hylander Møller Morten  

Intensive Care Medicine, Vol. 40, Iss. 1, 2014-01 ,pp. : 11-22

Springer Publishing Company

Access to resources Recommend Favorite

Safety and Efficacy of Levetiracetam for Critically Ill Patients with Seizures

By Nau Karen  

Neurocritical Care, Vol. 11, Iss. 1, 2009-08 ,pp. : 34-37

Humana Press, Inc

Access to resources Recommend Favorite